Back to briefing
Research St. Gallen, Switzerland

AI Ambient Scribe in Psychiatry

A clinical trial at Psychiatrie St. Gallen in Switzerland tests an AI tool that records appointments and drafts clinical notes to see if it reduces clinicians’ documentation time, maintains or improves note quality, and affects patients’ perception of the therapeutic relationship. The study compares clinicians using the AI from 14 August 2026 to those continuing usual note‑writing until the end of November 2026, with note quality evaluated in December 2026. Patients complete a brief anonymous survey and consent to review of their initial assessment report.

Published
20 Aug 2026
2 min read 1 source
Intelligence brief
St. Gallen, Switzerland / Research
CH

A clinical trial at Psychiatrie St. Gallen in Switzerland tests an AI tool that records appointments and drafts clinical notes to see if it reduces clinicians’ documentation time, maintains or improves note quality, and affects patients’ perception of the therapeutic relationship. The study compares clinicians using the AI from 14 August 2026 to those continuing usual note‑writing until the end of November 2026, with note quality evaluated in December 2026. Patients complete a brief anonymous survey and consent to review of their initial assessment report.

Why it matters

The trial evaluates an AI‑assisted documentation system in a Swiss psychiatric setting, informing the feasibility and patient impact of AI tools in Swiss healthcare and guiding future AI integration in clinical practice.

Primary source record
ClinicalTrials.gov

Original source record. Open the original record to verify the underlying announcement.

Your privacy choices

Allow optional Google Analytics to help us understand how the site is used. Analytics stays off unless you accept. Privacy details